Nutrition
Guidelines and Recommendations

Below are selected prevention and treatment guidelines, recommendations, frameworks, approaches, and other documents related to nutrition. Also see related links on this page.

Recommendations: Nutrition and Physical Activity
http://www.cdc.gov/nccdphp/dnpa/recommendations.htm
CDC's Nutrition and Physical Activity Program develops recommendations in several topic areas. The program also partners with other government agencies to provide comprehensive information for partners, public health educators, and the public. In this Web site, you will find information on, physical activity, healthy eating, overweight and obesity, pediatric growth, and iron status.

Neurologic Impairment in Children Associated with Maternal Dietary Deficiency of Cobalamin - Georgia, 2001 (2003)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5204a1.htm
PDF
http://www.cdc.gov/mmwr/PDF/wk/mm5204.pdf
This report summarizes the two cases of cobalamin (vitamin B12) deficiency and provides guidance for health-care providers on identifying and preventing cobalamin deficiency among breastfed infants of vegetarian mothers.

Hepatic Toxicity Possibly Associated with Kava-Containing Products - United States, Germany, and Switzerland, 1999-2002 (2002)
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5147a1.htm
PDF
http://www.cdc.gov/mmwr/PDF/wk/mm5147.pdf
This report presents the investigation of the two U.S. cases of liver failure associated with kava-containing dietary supplement products and summarizes the European cases. In the United States, kava-containing products are sold as dietary supplements and marketed for the treatment of anxiety, occasional insomnia, premenstrual syndrome, and stress. Since 1999, health-care professionals in Germany, Switzerland, and the United States have reported the occurrence of severe hepatic toxicity possibly associated with the consumption of products containing kava (i.e., kava kava or Piper methysticum). Eight females and two males who used kava products had liver failure and underwent subsequent liver transplantation. On March 25, 2002, in response to five such case reports (four in Europe and one in the United States), the Food and Drug Administration (FDA) issued a consumer advisory and subsequently completed an investigation already underway of a similar U.S. case. FDA continues to advise consumers and health-care providers about the potential risk associated with the use of kava-containing products.

Recommendations to Prevent and Control Iron Deficiency in the United States (1998)
http://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm
PDF
http://www.cdc.gov/mmwr/PDF/rr/rr4703.pdf
To address the changing epidemiology of iron deficiency in the United States, CDC staff in consultation with experts developed new recommendations for use by primary health-care providers to prevent, detect, and treat iron deficiency. These recommendations update the 1989 "CDC Criteria for Anemia in Children and Childbearing-Aged Women" (MMWR 1989;38(22):400-4) and are the first comprehensive CDC recommendations to prevent and control iron deficiency. The CDC recommendations in this report -- including those for pregnant women -- were developed for practical use in primary health-care and public health settings.

Related Links

Nutrition: Women’s Health Topics A-Z
http://www.cdc.gov/women/az/nutri.htm

Guide to Community Preventive Services
http://www.cdc.gov/epo/communityguide.htm

This site contains documents in PDF format. You will need Adobe Acrobat Reader to access the file. If you do not have the Acrobat Reader, you may download a free copy from the Adobe Web site.
 

Home | Site Map | Contact Us
Privacy Policy | Disclaimer | Accessibility
CDC Home | Search | Health Topics A-Z

This page last reviewed November 29, 2004
URL: http://www.cdc.gov/women/gderecom/nutri.htm

US Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Women's Health